Trial Management STREAM

31. What Is The Secret To Ongoing TMF Health? 8/22/2023

    Delve into specific tactics clinical teams can utilize for establishing immediate and long-lasting improvements to their TMF business processes.

32. Are Resource Constraints Impacting Your TMF Health? 8/22/2023

    Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.

33. Why Disclosure Assessments Are The First Step To Improvement 1/8/2019

    Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.

34. At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights 5/20/2025

    Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

35. Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm 9/9/2022

    This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.

36. Practical Approaches To Faster Study Start-Ups 9/25/2023

    Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.

37. Are Your Clinical Study Meetings Building Momentum, Or Wasting Time? 9/17/2025

    Transforming passive clinical trial meetings into active catalysts for success, aligning teams and accelerating timelines.

38. How To Boost Disclosure Efficiencies With Outsourcing 11/1/2018

    In this webinar, you’ll hear about exciting new advisory and managed disclosure services from TrialScope, including: compliance, policy and process assessments, as well as plain-language summaries, protocol registration, results posting, and redaction services.

39. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

40. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.